HUP0000756A2 - Levobupivakain vagy ropivakain alkalmazása migrén kezelésére alkalmas gyógyszerkészítmények előállítására - Google Patents

Levobupivakain vagy ropivakain alkalmazása migrén kezelésére alkalmas gyógyszerkészítmények előállítására

Info

Publication number
HUP0000756A2
HUP0000756A2 HU0000756A HUP0000756A HUP0000756A2 HU P0000756 A2 HUP0000756 A2 HU P0000756A2 HU 0000756 A HU0000756 A HU 0000756A HU P0000756 A HUP0000756 A HU P0000756A HU P0000756 A2 HUP0000756 A2 HU P0000756A2
Authority
HU
Hungary
Prior art keywords
levobupivacaine
ropivacaine
pharmaceutical compositions
compositions suitable
treating migraine
Prior art date
Application number
HU0000756A
Other languages
English (en)
Inventor
Ian Ashley Evetts
Simon John Gunning
Original Assignee
Darwin Discovery Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Limited filed Critical Darwin Discovery Limited
Publication of HUP0000756A2 publication Critical patent/HUP0000756A2/hu
Publication of HUP0000756A3 publication Critical patent/HUP0000756A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány a levobupivakain vagy a ropivakain migrén kezeléséreszolgáló gyógyszerkészítmények előállítására történő felhasználásáravonatkozik. Ó
HU0000756A 1997-03-03 1998-03-03 Use of levobupivacaine or ropivacaine for producing pharmaceutical compositions suitable for treating migraine HUP0000756A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9704349.1A GB9704349D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use
PCT/GB1998/000662 WO1998038998A1 (en) 1997-03-03 1998-03-03 The use of levobupivacaine or ropivacaine in treating migraine

Publications (2)

Publication Number Publication Date
HUP0000756A2 true HUP0000756A2 (hu) 2000-10-28
HUP0000756A3 HUP0000756A3 (en) 2000-12-28

Family

ID=10808600

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000756A HUP0000756A3 (en) 1997-03-03 1998-03-03 Use of levobupivacaine or ropivacaine for producing pharmaceutical compositions suitable for treating migraine

Country Status (15)

Country Link
US (1) US6019994A (hu)
EP (1) EP0967979A1 (hu)
JP (1) JP2001515479A (hu)
KR (1) KR20000075895A (hu)
CN (1) CN1128620C (hu)
AU (1) AU731127B2 (hu)
BR (1) BR9808299A (hu)
CA (1) CA2280135A1 (hu)
GB (1) GB9704349D0 (hu)
HU (1) HUP0000756A3 (hu)
IL (1) IL131085A0 (hu)
NO (1) NO994258L (hu)
PL (1) PL335562A1 (hu)
WO (1) WO1998038998A1 (hu)
ZA (1) ZA981781B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
EP0999839B1 (en) * 1997-07-21 2004-06-23 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
WO2000044432A1 (en) 1999-01-27 2000-08-03 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
AU2100901A (en) * 1999-12-15 2001-06-25 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
US20070225781A1 (en) * 2006-03-21 2007-09-27 Nidus Medical, Llc Apparatus and methods for altering temperature in a region within the body
DE102008037682A1 (de) * 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
JP2016508956A (ja) * 2012-05-10 2016-03-24 セリックスビオ プライヴェート リミテッド 局所疼痛の治療のための組成物と治療法
CN106214670B (zh) * 2016-07-25 2020-12-29 上海璃道医药科技有限公司 酰胺类药物的用途
WO2023215604A1 (en) 2022-05-05 2023-11-09 Pfof Llc Anesthetic nerve block and method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2135673A (en) * 1983-02-25 1984-09-05 Raychem Ltd Curable fabric
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
AU704806B2 (en) * 1995-04-13 1999-05-06 Darwin Discovery Limited Levobupivacaine and its use as an anaesthetic in pregnant women
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
EP0999839B1 (en) * 1997-07-21 2004-06-23 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches

Also Published As

Publication number Publication date
EP0967979A1 (en) 2000-01-05
US6019994A (en) 2000-02-01
BR9808299A (pt) 2002-05-21
CN1249685A (zh) 2000-04-05
AU6630898A (en) 1998-09-22
WO1998038998A1 (en) 1998-09-11
GB9704349D0 (en) 1997-04-23
PL335562A1 (en) 2000-05-08
IL131085A0 (en) 2001-01-28
CN1128620C (zh) 2003-11-26
KR20000075895A (ko) 2000-12-26
AU731127B2 (en) 2001-03-22
CA2280135A1 (en) 1998-09-11
JP2001515479A (ja) 2001-09-18
HUP0000756A3 (en) 2000-12-28
NO994258D0 (no) 1999-09-02
ZA981781B (en) 1999-03-03
NO994258L (no) 1999-11-02

Similar Documents

Publication Publication Date Title
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
ATE250605T1 (de) Piperidin verbindung zur behandlung von psoriasis
RS20050070A (en) Use of 1kb kinase inhibitors for the treatment of pain
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
ATE282607T1 (de) Tryptase-inhibitoren
HUP0000756A2 (hu) Levobupivakain vagy ropivakain alkalmazása migrén kezelésére alkalmas gyógyszerkészítmények előállítására
DK0989973T3 (da) Chalconer med antiproliferativ aktivitet
GEP20053590B (en) Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
ATE332688T1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
ATE476987T1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
DE60130659D1 (de) Therapeutische verbindungen und verfahren
YU22802A (sh) Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina
SE0004827D0 (sv) Therapeutic compounds
HUP0401895A2 (hu) Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
HUP0002717A2 (hu) 13-Dezoxiantraciklin-származékok és előállítási eljárásaik
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
PL375354A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal